Logo image of APR

APRIA INC (APR) Stock Fundamental Analysis

NASDAQ:APR - Nasdaq - Common Stock

37.5  +0.01 (+0.03%)

After market: 37.51 +0.01 (+0.03%)

Fundamental Rating

2

Taking everything into account, APR scores 2 out of 10 in our fundamental rating. APR was compared to 103 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of APR have multiple concerns. APR is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year APR was profitable.
APR Yearly Net Income VS EBIT VS OCF VS FCFAPR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 50M 100M 150M 200M

1.2 Ratios

Industry RankSector Rank
ROA 8.36%
ROE 163.17%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
APR Yearly ROA, ROE, ROICAPR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 0 100 -100

1.3 Margins

Industry RankSector Rank
OM 8.65%
PM (TTM) 5.66%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
APR Yearly Profit, Operating, Gross MarginsAPR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 20 40 60

More info and screens

1

2. Health

2.1 Basic Checks

Compared to 1 year ago, APR has more shares outstanding
APR has a better debt/assets ratio than last year.
APR Yearly Shares OutstandingAPR Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 10M 20M 30M
APR Yearly Total Debt VS Total AssetsAPR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 200M 400M 600M

2.2 Solvency

Based on the Altman-Z score of 1.39, we must say that APR is in the distress zone and has some risk of bankruptcy.
A Debt/Equity ratio of 8.58 is on the high side and indicates that APR has dependencies on debt financing.
Industry RankSector Rank
Debt/Equity 8.58
Debt/FCF N/A
Altman-Z 1.39
ROIC/WACCN/A
WACCN/A
APR Yearly LT Debt VS Equity VS FCFAPR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 1.09 indicates that APR should not have too much problems paying its short term obligations.
APR has a Quick Ratio of 1.06. This is a normal value and indicates that APR is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.09
Quick Ratio 1.06
APR Yearly Current Assets VS Current LiabilitesAPR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 100M 200M 300M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 29.97% over the past year.
Measured over the past years, APR shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -11.35% on average per year.
The Revenue has been growing slightly by 3.30% in the past year.
Measured over the past years, APR shows a small growth in Revenue. The Revenue has been growing by 1.62% on average per year.
EPS 1Y (TTM)29.97%
EPS 3Y65.99%
EPS 5Y-11.35%
EPS Q2Q%-98.12%
Revenue 1Y (TTM)3.3%
Revenue growth 3Y1.02%
Revenue growth 5Y1.62%
Sales Q2Q%0.93%

3.2 Future

The Earnings Per Share is expected to grow by 7.08% on average over the next years.
APR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.70% yearly.
EPS Next Y5.86%
EPS Next 2Y6.66%
EPS Next 3Y6.76%
EPS Next 5Y7.08%
Revenue Next Year5.14%
Revenue Next 2Y4.96%
Revenue Next 3Y4.61%
Revenue Next 5Y4.7%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
APR Yearly Revenue VS EstimatesAPR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
APR Yearly EPS VS EstimatesAPR Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 0.5 1 1.5 2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 21.43, APR is valued on the expensive side.
Compared to an average S&P500 Price/Earnings ratio of 27.48, APR is valued a bit cheaper.
Based on the Price/Forward Earnings ratio of 20.24, the valuation of APR can be described as rather expensive.
The average S&P500 Price/Forward Earnings ratio is at 36.52. APR is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 21.43
Fwd PE 20.24
APR Price Earnings VS Forward Price EarningsAPR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.98
APR Per share dataAPR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)3.66
PEG (5Y)N/A
EPS Next 2Y6.66%
EPS Next 3Y6.76%

More info and screens

0

5. Dividend

5.1 Amount

APR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

APRIA INC

NASDAQ:APR (3/28/2022, 8:26:58 PM)

After market: 37.51 +0.01 (+0.03%)

37.5

+0.01 (+0.03%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-28 2022-02-28/bmo
Earnings (Next)05-11 2022-05-11
Inst Owners0%
Inst Owner Change0%
Ins Owners0.02%
Ins Owner Change0%
Market Cap1.34B
Analysts46.67
Price Target39.1 (4.27%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 21.43
Fwd PE 20.24
P/S 1.17
P/FCF N/A
P/OCF N/A
P/B 33.64
P/tB N/A
EV/EBITDA 6.98
EPS(TTM)1.75
EY4.67%
EPS(NY)1.85
Fwd EY4.94%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS32.14
BVpS1.11
TBVpSN/A
PEG (NY)3.66
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 8.36%
ROE 163.17%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 8.65%
PM (TTM) 5.66%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover1.48
Health
Industry RankSector Rank
Debt/Equity 8.58
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.09
Quick Ratio 1.06
Altman-Z 1.39
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)29.97%
EPS 3Y65.99%
EPS 5Y-11.35%
EPS Q2Q%-98.12%
EPS Next Y5.86%
EPS Next 2Y6.66%
EPS Next 3Y6.76%
EPS Next 5Y7.08%
Revenue 1Y (TTM)3.3%
Revenue growth 3Y1.02%
Revenue growth 5Y1.62%
Sales Q2Q%0.93%
Revenue Next Year5.14%
Revenue Next 2Y4.96%
Revenue Next 3Y4.61%
Revenue Next 5Y4.7%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A